Macromolecular Crowding Enhances Matrix Protein Deposition in Tissue-Engineered Vascular Grafts

被引:0
|
作者
Liu, Qing [1 ,2 ]
Liu, Jiang [3 ]
Sun, Xu-Heng [1 ,2 ]
Xu, Jian-Yi [1 ,2 ]
Xiao, Cong [1 ,2 ]
Jiang, Hong-Jing [1 ,2 ]
Wu, Yin-Di [1 ,2 ]
Lin, Zhan-Yi [1 ,2 ,4 ,5 ]
机构
[1] South China Univ Technol, Sch Med, Guangzhou, Peoples R China
[2] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Cardiovasc Inst,Dept Cardiol, Guangzhou, Peoples R China
[3] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Pharm, Guangzhou, Peoples R China
[4] Ji Hua Inst Biomed Engn Technol, Ji Hua Lab, Foshan, Peoples R China
[5] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Cardiol, 106 Zhongshan Second Rd, Guangzhou 510080, Guangdong, Peoples R China
关键词
macromolecular crowding; excluded volume effect; extracellular matrix; tissue-engineered vascular grafts; PROCOLLAGEN C-PROTEINASE; IN-VITRO; GENE-EXPRESSION; 3D COLLAGEN; FIBROBLASTS; DISEASE; VESSEL; DLS;
D O I
10.1089/ten.tea.2023.0290
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Successful in vitro culture of small-diameter tissue-engineered vascular grafts (TEVGs) requires rapid deposition of biomacromolecules secreted by vascular smooth muscle cells in a polyglycolic acid mesh scaffold's three-dimensional (3D) porous environment. However, common media have lower crowding conditions than in vivo tissue fluids. In addition, during the early stages of construction, most of the biomolecules secreted by the cells into the medium are lost, which negatively affects the TEVG culture process. In this study, we propose the use of macromolecular crowding (MMC) to enhance medium crowding to improve the deposition and self-assembly efficiency of major biomolecules in the early stages of TEVG culture. The addition of carrageenan significantly increased the degree of MMC in the culture medium without affecting cell viability, proliferation, and metabolic activity. Protein analysis demonstrated that the deposition of collagen types I and III and fibronectin increased significantly in the cell layers of two-dimensional and 3D smooth muscle cell cultures after the addition of a MMC agent. Collagen type I in the culture medium decreased significantly compared with that in the medium without a MMC agent. Scanning electron microscopy demonstrated that MMC agents considerably enhanced the formation of matrix protein structures during the early stages of 3D culture. Hence, MMC modifies the crowding degree of the culture medium, resulting in the rapid formation of numerous matrix proteins and fiber structures.Impact Statement Small-diameter tissue-engineered vascular grafts (TEVGs) are one of the most promising means of treating cardiovascular diseases; however, the in vitro construction of TEVGs has some limitations, such as slow deposition of extracellular matrix (ECM), long culture period, and poor mechanical properties. We hypothesized that macromolecular crowding can increase the crowding of the culture medium to construct a more bionic microenvironment, which enhances ECM deposition in the medium to the cell layer and reduces collagen loss, accelerating and enhancing TEVG culture and construction in vitro.
引用
收藏
页码:473 / 484
页数:12
相关论文
共 50 条
  • [21] Effect of implantation site on outcome of tissue-engineered vascular grafts
    Sologashvili, Tornike
    Saat, Shahrul A.
    Tille, Jean-Christophe
    De Valence, Sarra
    Mugnai, Damiano
    Giliberto, Jean Pierre
    Dillon, Jeswant
    Yakub, Azhari
    Dimon, Zamrin
    Gurny, Robert
    Walpoth, Beat H.
    Moeller, Michael
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2019, 139 : 272 - 278
  • [22] Multiple Pulmonary Artery Plasty With Tissue-Engineered Vascular Grafts
    Nagase, Takashi
    Yamagishi, Masaaki
    Maeda, Yoshinobu
    Asada, Satoshi
    Hongu, Hisayuki
    Yamashita, Eijiro
    Nakai, Rie
    Yaku, Hitoshi
    ANNALS OF THORACIC SURGERY, 2023, 115 (01): : E11 - E13
  • [23] Tissue-engineered vascular grafts: does cell seeding matter?
    Mirensky, Tamar L.
    Hibino, Narutoshi
    Sawh-Martinez, Rajendra F.
    Yi, Tai
    Villalona, Gustavo
    Shinoka, Toshiharu
    Breuer, Christopher K.
    JOURNAL OF PEDIATRIC SURGERY, 2010, 45 (06) : 1299 - 1305
  • [24] Acellular Small-Diameter Tissue-Engineered Vascular Grafts
    Li, Zhen
    Li, Xinda
    Xu, Tao
    Zhang, Lei
    APPLIED SCIENCES-BASEL, 2019, 9 (14):
  • [25] Tissue-engineered Vascular Grafts: Balance of the Four Major Requirements
    Wu, Jingxian
    Hu, Changming
    Tang, Zengchao
    Yu, Qian
    Liu, Xiaoli
    Chen, Hong
    COLLOID AND INTERFACE SCIENCE COMMUNICATIONS, 2018, 23 : 34 - 44
  • [26] Human iPSCs Stretch to Improve Tissue-Engineered Vascular Grafts
    Abutaleb, Nadia O.
    Truskey, George A.
    CELL STEM CELL, 2020, 26 (02) : 136 - 137
  • [27] Heparin-Eluting Tissue-Engineered Bioabsorbable Vascular Grafts
    Matsuzaki, Yuichi
    Ulziibayar, Anudari
    Shoji, Toshihiro
    Shinoka, Toshiharu
    APPLIED SCIENCES-BASEL, 2021, 11 (10):
  • [28] Zoledronate alters natural progression of tissue-engineered vascular grafts
    Chang, Yu-Chun
    Li, Junlang
    Mirhaidari, Gabriel
    Zbinden, Jacob
    Barker, Jenny
    Blum, Kevin
    Reinhardt, James
    Best, Cameron
    Kelly, John
    Shoji, Toshihiro
    Yi, Tai
    Breuer, Christopher
    FASEB JOURNAL, 2021, 35 (10):
  • [29] In Vivo Applications of Electrospun Tissue-Engineered Vascular Grafts: A Review
    Rocco, Kevin A.
    Maxfield, Mark W.
    Best, Cameron A.
    Dean, Ethan W.
    Breuer, Christopher K.
    TISSUE ENGINEERING PART B-REVIEWS, 2014, 20 (06) : 628 - 640
  • [30] Development of long in vivo tissue-engineered "Biotube" vascular grafts
    Nakayama, Yasuhide
    Furukoshi, Maya
    Terazawa, Takeshi
    Iwai, Ryosuke
    BIOMATERIALS, 2018, 185 : 232 - 239